Isomeranzin

CAS No. 1088-17-1

Isomeranzin( Isomerazin )

Catalog No. M23292 CAS No. 1088-17-1

Isomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 300 In Stock
10MG 511 In Stock
25MG 807 In Stock
50MG 1062 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isomeranzin
  • Note
    Research use only, not for human use.
  • Brief Description
    Isomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.
  • Description
    Isomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Isomerazin
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK|NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1088-17-1
  • Formula Weight
    260.3
  • Molecular Formula
    C15H16O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (384.19 mM)
  • SMILES
    CC(C)C(Cc(c(O1)c(cc2)C=CC1=O)c2OC)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ERK-IN-3

    ERK-IN-3 is a potent and orally active inhibitor of ERK. It inhibits ERK1/2 with low single-digit nM IC50 values. It can be used for the research of cancers driven by RAS mutations.

  • VX-11e

    A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.

  • ZINC12409120

    ZINC12409120 (R-4584) is a selective ERK inhibitor.ZINC12409120 inhibits ERK with an IC50 of 5.0 μM.ZINC12409120 inhibits ERK activity by interfering with FGF23:α-Klotho interaction.